Fmr LLC Theravance Biopharma, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,585 shares of TBPH stock, worth $13,868. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,585

Previous 2,170 26.96%

Holding current value

$13,868

Previous $19,000 31.58%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$8.29 - $9.92 $4,849 - $5,803	-585 Reduced 26.96%	1,585 $13,000
Q1 2024 May 13, 2024	SELL	$8.22 - $11.59 $89,524 - $126,226	-10,891 Reduced 83.39%	2,170 $19,000
Q4 2023 Feb 13, 2024	SELL	$8.58 - $11.4 $24,367 - $32,376	-2,840 Reduced 17.86%	13,061 $146,000
Q3 2023 Nov 13, 2023	SELL	$8.38 - $10.44 $7.95 Million - $9.91 Million	-948,923 Reduced 98.35%	15,901 $137,000
Q2 2023 Aug 11, 2023	SELL	$10.16 - $11.92 $7.62 Million - $8.93 Million	-749,565 Reduced 43.72%	964,824 $9.99 Million
Q1 2023 May 11, 2023	SELL	$9.87 - $11.44 $7.49 Million - $8.68 Million	-759,083 Reduced 30.69%	1,714,389 $18.6 Million
Q4 2022 Feb 13, 2023	SELL	$9.65 - $11.34 $644,764 - $757,682	-66,815 Reduced 2.63%	2,473,472 $27.8 Million
Q3 2022 Nov 10, 2022	SELL	$8.39 - $10.22 $1.33 Million - $1.62 Million	-158,063 Reduced 5.86%	2,540,287 $25.8 Million
Q2 2022 Aug 12, 2022	BUY	$8.41 - $10.34 $28,913 - $35,548	3,438 Added 0.13%	2,698,350 $24.4 Million
Q1 2022 May 13, 2022	BUY	$8.33 - $12.96 $887,403 - $1.38 Million	106,531 Added 4.12%	2,694,912 $25.8 Million
Q4 2021 Feb 14, 2022	SELL	$7.42 - $11.05 $612,150 - $911,625	-82,500 Reduced 3.09%	2,588,381 $28.6 Million
Q3 2021 Nov 15, 2021	SELL	$6.77 - $14.41 $55 Million - $117 Million	-8,120,982 Reduced 75.25%	2,670,881 $19.8 Million
Q2 2021 Aug 13, 2021	BUY	$14.52 - $22.46 $157 Million - $242 Million	10,791,863 New	10,791,863 $157 Million

Others Institutions Holding TBPH

# of Institutions

133

Shares Held

48.7M

Call Options Held

13.9K

Put Options Held

3.1K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $584M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account